Linda Picker Johnson
Adult Health · Grants Pass, ORNPI 1427028224
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,256 and has fallen 92.8% since, to $90 in 2024. Among adult health clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$547
- AbbVie$490
- Novo Nordisk$462
- Lilly USA, LLC$307
- Astellas Pharma US Inc$199
- Johnson & Johnson$194
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,23295%
- Education$1855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $547 |
| AbbVie | 42 | $490 |
| Novo Nordisk | 23 | $462 |
| Lilly USA, LLC | 12 | $307 |
| Astellas Pharma US Inc | 3 | $199 |
| Johnson & Johnson | 23 | $194 |
| GSK | 8 | $172 |
| Otsuka America Pharmaceutical, Inc. | 7 | $156 |
| Bayer | 6 | $129 |
| Biohaven Pharmaceuticals, Inc. | 1 | $100 |
| Alkermes, Inc. | 5 | $92 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $88 |
| Dexcom, Inc. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $61 |
| Amarin Pharma, Inc. | 3 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Amgen | 2 | $41 |
| Grifols USA, LLC | 2 | $32 |
| Mylan Specialty L.p. | 1 | $22 |
| Gilead | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,417 in reported general payments places this provider in the 90th percentile of 96 adult health providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 22 | $23,155 |
| OzempicSemaglutide | 18 | $20,835 |
| KerendiaFinerenone | 12 | $13,115 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,665 |
| Levothyroxine Sodium | 38 | $579 |
| Atorvastatin Calcium | 41 | $576 |
| Tamsulosin Hcl | 14 | $562 |
| Potassium Chloride | 14 | $509 |
| Omeprazole | 30 | $500 |
| Metoprolol Succinate | 20 | $474 |
| Metformin Hcl | 33 | $457 |
| Ropinirole Hcl | 14 | $443 |
| Gabapentin | 15 | $404 |
| FenofibrateFenofibrate Nanocrystallized | 11 | $354 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $331 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $547 | $23,15522 claims |
| Novo NordiskOzempic | $462 | $20,83518 claims |
| BayerKerendia | $129 | $13,11512 claims |
| GSKTrelegy Ellipta | $172 | $9,66511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 96 adult health providers in Oregon.
Other adult health in Grants Pass
- Derek KordenbrockGrants Pass$876
- Victoria VandykeGrants Pass$212
- Robert AnthonyGrants Pass$135
- Lakshi AldredgePortland$393K
- Deborah JonesLake Oswego$44K
- Erin MyklebustPortland$14K
- Yasmine LeePortland$11K
- Terri WarrenPortland$10K
- Brenda BrewerTualatin$7K
- Rachael GreerSeaside$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.